Search results
FDA signs off on updated protein-based Covid-19 vaccine from Novavax
CNN via Yahoo News· 7 months agoThe US Food and Drug Administration on Tuesday authorized Novavax’s updated protein-based Covid-19...
US FDA authorizes Novavax's updated COVID shot, shares rise
Reuters via Yahoo News· 7 months ago(Reuters) -The U.S. Food and Drug Administration said on Tuesday it authorized an updated version of...
Novavax’s COVID-19 vaccine gets the green light from the FDA, giving third option for protection
Salon via Yahoo News· 7 months agoNovavax Vaccine Photo Illustration by Nikos Pekiaridis/NurPhoto via Getty Images On Tuesday, the...
Novavax Jumps After Pledging To Update Its Covid Shot; Pfizer, Moderna Slip
Investor's Business Daily· 1 year agoNovavax plans to update its Covid shot for new variants, and NVAX stock outperformed its vaccine...
UPDATE 4-U.S. CDC recommends Novavax COVID vaccine for adults
Reuters via Yahoo Finance· 2 years agoThe U.S. Centers for Disease Control and Prevention (CDC) on Tuesday recommended use of Novavax...
Another updated COVID-19 vaccine gets federal approval — here’s what makes this one different
Deseret News via Yahoo News· 7 months agoNovavax’s updated COVID-19 vaccine is approved by the federal government for anyone 12 and older....
Does Novavax's Covid vaccine cause fewer side effects?
NBC Universal via AOL· 5 months agoErin Kissane, a co-founder of the COVID Tracking Project, rolled up her sleeve for the Novavax...
Novavax Surges After FDA Signs Off On Its Updated Covid Shot, Joining Pfizer, Moderna
Investor's Business Daily· 7 months agoThe Food and Drug Administration signed off on Novavax's updated Covid booster late Tuesday, and...
Novavax stock plunges 25% after the COVID-19 vaccine maker warns it could go out of business
Business Insider via Yahoo Finance· 1 year agoCOVID-19 vaccine.Dado Ruvic/Reuters Novavax shares sank 25% after it said it has "substantial doubt"...
Novavax (NVAX) to Report Q4 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 1 year agoWe expect investors to focus on the sales performance of Novavax, Inc.’s NVAX protein-based COVID-19...